Compare Novartis AG (NVS) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Impinj Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Impinj Inc trades at $137.09 (market cap $4.19B). The key difference: Novartis AG is far larger — about 69.3× Impinj Inc's market cap, and Novartis AG pays a 3.17% dividend while Impinj Inc pays none. Which is the better fit depends on your goals.
| NVS | PI | |
|---|---|---|
Market Cap | $290.25B | $4.19B |
Sector | Health | Technology |
52-Week High | $168.62 | $241.91 |
52-Week Low | $113.50 | $91.34 |
Enterprise Value | $330.27B | $4.33B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
